Skip to main navigation Skip to search Skip to main content

Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India

  • Purvish M. Parikh*
  • , Gouri Shankar Bhattacharyya
  • , Ghanshyam Biswas
  • , Arvind Krishnamurty
  • , Dinesh Doval
  • , Anil Heroor
  • , Sanjay Sharma
  • , Ramakant Deshpande
  • , Harit Chaturvedi
  • , S. P. Somashekhar
  • , Govind Babu
  • , G. Krishna Reddy
  • , Diptendra Sarkar
  • , Chirag Desai
  • , Hemant Malhotra
  • , Nitesh Rohagi
  • , Ajay Bapna
  • , S. S. Alurkar
  • , Prasad Krishna
  • , S. V.S. Deo
    • Anurag Shrivastava, Prakash Chitalkar, Saroj Kumar Majumdar, Devanhalli Vijay, Aniket Thoke, K. S. Udupa, Jyoti Bajpai, G. K. Rath, Palanki Satya Dattatreya, Shailesh Bondarde, Shekhar Patil
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India'. Together they form a unique fingerprint.
Sort by

INIS

Medicine and Dentistry